Conditions Linked to Weight: what to know and who to ask

Key takeaways

• The NIH lists type 2 diabetes, high blood pressure, heart disease, fatty liver disease, sleep apnea and many other conditions among the health risks of excess weight.^[1]
• Losing 5% to 7% of starting weight may prevent or delay type 2 diabetes, and 3% to 5% may reduce liver fat.^[1]
• In 25 trials, losing about 5 kg lowered blood pressure by about 4.4/3.6 mm Hg on average.^[7]
• Some medicines (for depression, epilepsy, psychosis, diabetes, blood pressure, steroids, antihistamines) and conditions (PCOS, Cushing's, hypothyroidism) can contribute to weight gain.^[2]
• In August 2021 to August 2023, 40.3% of U.S. adults had obesity.^[3]

In short: Many common health conditions are linked to weight, including insulin resistance, type 2 diabetes, high blood pressure, sleep apnea, fatty liver disease and PCOS, and some medicines and hormone conditions can cause weight gain. The link often runs both ways, and modest weight loss can make a real difference: 5% to 7% lowered the risk of type 2 diabetes in a major trial, and 3% to 5% can reduce liver fat. This hub explains each condition in plain language, what tests a clinician may order and which treatments are discussed. It is information only: the next step is always an evaluation by a licensed clinician.

Start here, 1-2-3

Our BMI calculator and waist-to-height calculator give rough screening numbers; they are not a diagnosis. Weight is only one piece of health, and people of every size can have these conditions.

Why weight and health are connected

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) lists the health risks linked to overweight and obesity: type 2 diabetes, high blood pressure, heart disease, stroke, metabolic syndrome, fatty liver diseases, some cancers, sleep apnea and asthma, osteoarthritis, gout, gallbladder and pancreas diseases, kidney disease, pregnancy complications, fertility problems, sexual function problems and mental health conditions. It also notes that nearly 9 in 10 people with type 2 diabetes have overweight or obesity.

The link goes the other way too. Some conditions and medicines make weight gain more likely, and the NIDDK lists PCOS, Cushing’s syndrome and hypothyroidism among the endocrine diseases that can contribute to obesity, along with depression, chronic stress and too little sleep. Obesity is common: in the CDC’s most recent national survey, 40.3% of adults had obesity and 9.4% had severe obesity, and the share was highest among adults aged 40 to 59.

35.5%Ages 20 to 39

46.4%Ages 40 to 59

38.9%Ages 60 and older

Adults with obesity by age group, August 2021 to August 2023

Item	Value
Ages 20 to 39	35.5%
Ages 40 to 59	46.4%
Ages 60 and older	38.9%

Overall 40.3%. Severe obesity rose from 7.7% to 9.7% (age-adjusted) since 2013-2014.

Source: CDC, NCHS Data Brief 508 (NHANES) (checked on October 6, 2026)

What modest weight loss can do

You do not need to reach a “goal weight” for health to improve. Different conditions respond to different amounts of weight loss, according to U.S. health agencies, guidelines and major trials:

Liver fat may be reduced (NIDDK, AASLD: 3% to 5%)3% of body weight

Type 2 diabetes risk lowered (NIDDK, DPP: 5% to 7%)5% of body weight

Periods and ovulation may improve, women with obesity (NIDDK)5% of body weight

MASH and liver scarring improve (AASLD: generally more than 10%)10% of body weight

Weight loss at which improvement starts, by condition

Item	Value
Liver fat may be reduced (NIDDK, AASLD: 3% to 5%)	3% of body weight
Type 2 diabetes risk lowered (NIDDK, DPP: 5% to 7%)	5% of body weight
Periods and ovulation may improve, women with obesity (NIDDK)	5% of body weight
MASH and liver scarring improve (AASLD: generally more than 10%)	10% of body weight

Each bar shows the lower end of the amount each source describes. Benefits are for groups, not a promise for one person.

Source: NIDDK Health Risks of Overweight and Obesity; AASLD Practice Guidance 2023 (checked on October 6, 2026)

Blood pressure responds too. A meta-analysis of 25 randomized trials with 4,874 participants, published in Hypertension in 2003, found that an average net weight loss of about 5.1 kg (11 pounds) lowered systolic blood pressure by 4.44 mm Hg and diastolic by 3.57 mm Hg. For sleep apnea, a 10% weight loss was linked to a 26% drop in breathing pauses per hour in a long-term study. Our how to lose weight hub covers the approaches, and the medical weight loss guide explains supervised care.

Insulin resistance and prediabetes

Insulin resistance means the body’s cells respond poorly to insulin, so blood sugar slowly rises. It usually has no symptoms. About 115.2 million U.S. adults had prediabetes in 2023, and in the Diabetes Prevention Program a lifestyle program aiming for 7% weight loss cut new cases of type 2 diabetes by 58%. Read insulin resistance: signs, testing and weight for the A1C and glucose ranges and the evidence.

Type 2 diabetes

About 40.1 million people in the U.S. have diabetes, and 27.6% of adults with diabetes do not know it. Weight loss can lead to remission for some people: in the DiRECT trial, 46% of people in a supervised weight-management program were in remission after a year. Some diabetes medicines lower weight and others raise it. Read type 2 diabetes and weight for trial results, low blood sugar cautions and coverage.

PCOS

Polycystic ovary syndrome affects an estimated 10% to 13% of reproductive-age women, and up to 70% are undiagnosed, according to the WHO. It is linked to insulin resistance and to higher weight, and modest weight loss can help cycles and fertility. Read PCOS and weight loss for diagnosis, the 2023 guideline on diet and medicines, and important pregnancy and contraception cautions with GLP-1 medicines.

Sleep apnea

Obstructive sleep apnea causes repeated pauses in breathing during sleep; obesity is one of its main risk factors. In December 2024 the FDA approved Zepbound as the first medicine for moderate to severe OSA in adults with obesity. Read sleep apnea and weight for how it is diagnosed, the trial results and the other treatments.

Fatty liver disease (MASLD and MASH)

Fat in the liver linked to metabolic health is now called MASLD; its inflammatory form, MASH, can scar the liver. More than 90% of people with severe obesity have fatty liver disease, the NIDDK reports. Two medicines have FDA accelerated approval for MASH with moderate to advanced scarring. Read fatty liver disease and weight for the FIB-4 test, how much weight loss helps and the approved treatments.

High blood pressure

Nearly half of U.S. adults (48.1%, 119.9 million) have high blood pressure, and only about 1 in 4 of them (22.5%) has it under control, according to the CDC. High blood pressure is one of the health risks of excess weight the NIDDK lists, and weight loss lowers it, as the meta-analysis above shows. Eating patterns matter too: our DASH diet guide explains the eating plan designed to lower blood pressure, with trial results. Some blood pressure medicines can also affect weight (see below), so review them with your prescriber rather than stopping any on your own.

Medicines that can cause weight gain

The NIDDK lists several groups of medicines that can contribute to weight gain:

• some medicines for epilepsy, depression and psychotic disorders;
• corticosteroids (steroid medicines such as prednisone);
• some diabetes medicines, such as insulin and sulfonylureas;
• some blood pressure medicines, such as beta-blockers, alpha-blockers and calcium channel blockers;
• antihistamines.

Hormone conditions: thyroid and Cushing’s syndrome

The NIDDK names hypothyroidism (an underactive thyroid) and Cushing’s syndrome (too much of the hormone cortisol) among the endocrine diseases that can contribute to weight gain. When a clinician evaluates weight, they may order blood tests to rule these out; our medical weight loss guide explains that evaluation, and the metabolism guide explains what thyroid changes can and cannot do to your weight. Some rare genetic conditions also cause obesity from childhood; they are covered on our Imcivree page.

Body changes: gynecomastia

Some conditions affect how the body looks rather than metabolic health. Gynecomastia, enlargement of breast gland tissue in males, affects about half of adolescent boys and around 65% of men aged 50 to 80, according to a review in American Family Physician. It is different from chest fat, which weight loss can reduce. Read gynecomastia: causes, weight loss and treatment options.

Who to ask

• Primary care clinician: the usual first stop for tests and referrals. Medicare covers intensive behavioral therapy for obesity in primary care for people with a BMI of 30 or more.
• Obesity medicine physician: doctors certified by the American Board of Obesity Medicine; see find an obesity medicine doctor.
• Specialists: endocrinologists (diabetes, thyroid, PCOS), sleep specialists, hepatologists or gastroenterologists (liver), gynecologists, and bariatric surgeons; see find a provider.
• Registered dietitian: turns the evidence into an eating plan for your condition and medicines.

If medicines or procedures come up, our medications hub lists what is FDA approved, with status badges, and the bariatric surgery guide explains surgical options. If you are wondering whether a clinic is trustworthy, read how to judge a weight-loss clinic.

All condition pages

Questions to ask a professional

• Based on my history, which conditions should I be tested for, and which tests?
• Could any of my medicines be contributing to weight gain, and is there an alternative?
• Should we check my thyroid or other hormones?
• How much weight loss would make a meaningful difference for my health?
• Which specialist, dietitian or program would you refer me to?

Frequently asked questions

Which health conditions are linked to weight?

The NIH lists type 2 diabetes, high blood pressure, heart disease, stroke, metabolic syndrome, fatty liver disease, some cancers, sleep apnea, asthma, osteoarthritis, gout, gallbladder and kidney disease, pregnancy and fertility problems, and mental health conditions, among others.

How much weight loss improves health?

Often less than people expect. The NIH says 5% to 7% may prevent or delay type 2 diabetes and 3% to 5% may reduce liver fat; liver scarring generally needs more than 10%, according to the AASLD.

Can a medical condition make it hard to lose weight?

Yes. The NIH names PCOS, Cushing's syndrome and hypothyroidism among the endocrine conditions that can contribute to obesity, and some medicines can cause weight gain. A clinician can check for these.

Which medicines cause weight gain?

The NIH lists some medicines for epilepsy, depression and psychotic disorders, corticosteroids, some diabetes medicines (insulin, sulfonylureas), some blood pressure medicines (beta-blockers, alpha-blockers, calcium channel blockers) and antihistamines. Never stop one on your own; ask about alternatives.

Does losing weight lower blood pressure?

Yes, on average. A meta-analysis of 25 trials found that about 5.1 kg of weight loss lowered systolic blood pressure by 4.44 mm Hg and diastolic by 3.57 mm Hg.

Should I be tested for diabetes or fatty liver?

Ask your clinician, especially if you have risk factors such as overweight, a family history of diabetes, high blood pressure or a history of gestational diabetes. Blood sugar tests and the FIB-4 liver score use routine blood work.

What kind of doctor treats weight-related conditions?

Start with primary care. Obesity medicine physicians, endocrinologists, sleep specialists, liver specialists, gynecologists, dietitians and bariatric surgeons may also be involved depending on the condition.

Does Medicare cover help with weight?

Medicare covers intensive behavioral therapy for obesity in primary care for people with a BMI of 30 or more, with visits continuing after six months for people who lose at least 3 kg. Medicine coverage depends on the condition and plan.

References

1. Health Risks of Overweight and Obesity. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). (accessed October 6, 2026) Government page
2. Factors Affecting Weight and Health. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). (accessed October 6, 2026) Government page
3. Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 (NCHS Data Brief 508). Centers for Disease Control and Prevention, National Center for Health Statistics, 2024. (accessed October 7, 2026) Government page
4. High Blood Pressure Facts. Centers for Disease Control and Prevention, 2026. (accessed October 6, 2026) Government page
5. National Diabetes Statistics Report. Centers for Disease Control and Prevention, 2026. (accessed October 6, 2026) Government page
6. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology, 2023. doi:10.1097/HEP.0000000000000323 · PMID 36727674 (accessed October 6, 2026) Guideline
7. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension, 2003. doi:10.1161/01.HYP.0000094221.86888.AE · PMID 12975389 (accessed October 6, 2026) Meta-analysis
8. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine, 2002. doi:10.1056/NEJMoa012512 · PMID 11832527 (accessed October 7, 2026) Randomized trial
9. Lean MEJ, Leslie WS, Barnes AC, et al.. Primary care-led weight management for remission of type 2 diabetes (DiRECT). The Lancet, 2018. doi:10.1016/S0140-6736(17)33102-1 · PMID 29221645 (accessed October 6, 2026) Randomized trial
10. Polycystic ovary syndrome (fact sheet). World Health Organization, 2026. (accessed October 6, 2026) Government page
11. Polycystic ovary syndrome. Office on Women's Health (HHS), 2025. (accessed October 6, 2026) Government page
12. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing. JAMA, 2000. doi:10.1001/jama.284.23.3015 · PMID 11122588 (accessed October 6, 2026) Other
13. FDA Approves First Medication for Obstructive Sleep Apnea. U.S. Food and Drug Administration, 2024. (accessed October 7, 2026) Government page
14. Definition and Facts of NAFLD and NASH. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). (accessed October 6, 2026) Government page
15. Dickson G. Gynecomastia. American Family Physician, 2012. (accessed October 6, 2026) Review
16. National Coverage Determination 210.12: Intensive Behavioral Therapy for Obesity. Centers for Medicare and Medicaid Services. (accessed October 6, 2026) Government page
17. American Board of Obesity Medicine. American Board of Obesity Medicine. (accessed October 6, 2026) Society statement

Facts checked on October 6, 2026

Educational information, not medical advice. Talk with a qualified healthcare professional about your own situation. In an emergency call 911.